Navigation Links
Bad Enzymes Found To Enable Brain Recovery Following Stroke

The same enzymes that cause brain damage following an acute attack of stroke could be beneficial some time later. This finding perhaps highlights that effective treatment // of stroke could be possible if administered few weeks following the stroke, instead of the treatment within couple of hours following stroke. Additionally, it could open avenues for the development of novel stroke treatment strategies and new generation drugs in treating the same.

The enzyme matrix metalloproteinase-9 (MMP-9) has been found to help in remodeling of the brain 14 days following stroke, in experiments conducted on animal mouse models by Harvard medical school researchers. The results of the study can be found in April issue of the Nature Medicine journal.

The enzymes serve to breakdown the complex structure that surrounds the cells, known as the extracellular matrix. The compound has been found to result in growth of new blood vessel in the damaged brain region. In addition it induces cell growth, cell differentiation and movement of the cells.

Stroke occurs due to a temporary loss of blood supply to the brain. This can occur either due to blockage of a blood vessel though blood clot or rupture of a blood vessel, supplying the brain. Following stroke, MMPs eat away the damaged brain tissue, increasing risk of inflammation and brain hemorrhage.

Current treat of stroke is directed at inhibiting the effect of these damage-causing MMPs. The only FDA-approved medication for the treatment of stroke is tissue plasminogen activator (tPA). This has to be administered with three hours of an acute stroke episode, to prevent irreversible damage to the brain.

Rats that were designed to mimic human models of stroke were given different doses of the MMP inhibitor, at different intervals. Administration of the inhibitor immediately following the stroke showed smaller brain damaged areas. No effect was observed when it was administered thr ee days following stroke. Extensive brain damage was seen when the inhibitor was given at 7 or 14 days after stroke.

Surprisingly, high levels of the MMPs were found adjacent to the damaged area, more specifically in the peri-infarct cortex, an area that enables recovery of the brain following stoke.

'We have mostly thought of MMPs as being bad. Our data strongly suggest that they play a totally different role during stroke recovery. The peri-infarct zone is very dynamic and potentially very malleable for long periods of time after stroke,' said Eng H. Lo, from the Neuroprotection Research Laboratory at Massachusetts General Hospital.

The researchers have however warned about the use of these compounds in stroke management, as the activity of the MMPs has to be regulated to ensure an optimal recovery of the stroke patient.


'"/>




Related medicine news :

1. Smoking Hazardous To The Enzymes System In Lungs
2. New Role of COX Enzymes Discovered
3. Immune System Gears Up by Specific Enzymes
4. Study Attributes Elevated Liver Enzymes in HIV/hepatitis to Coinfection Rather Than Antiretrovirals
5. Fluoride Found Effective in Osteoporosis
6. Implantable Contact Lens Found Safe and Effective
7. Cancer hazard Found With Animal-Based Nutrients
8. Processed Meat, Diabetes connection Found
9. Night Time Aspirin Regimen Found to Reduce Blood Pressure
10. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
11. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at Moffitt Cancer ... CentrePoint Data Hub in a sample of participants enrolled in an ongoing ... sleep monitoring solutions for the global scientific community. The company’s new CentrePoint Data ...
(Date:4/28/2017)... ... April 28, 2017 , ... NuevaCare, a leading home ... as Millbrae, Burlingame, and Palo Alto, is proud to announce information upgrades to its ... bookmark and read organized content on topics such as home care (generally) as well ...
(Date:4/27/2017)... DENVER (PRWEB) , ... April 27, 2017 , ... ... the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to ... enabled by the continuing support of the Jane and Leonard Korman Family Foundation. ...
(Date:4/27/2017)... ... 27, 2017 , ... The American Brain Foundation last night ... Neurology Award (PLINA). The couple joins a prestigious list of past PLINA winners, ... actor Michael J. Fox and former U.S. Attorney General Janet Reno. , Smith ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product ... oil many times purer and more potent than the market has seen before. Swissx ... Switzerland, as well as a patented chromatography process for extraction, to produce its CBD ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: